Literature DB >> 18509119

Exploiting a research underclass in phase 1 clinical trials.

Carl Elliott1, Roberto Abadie.   

Abstract

Mesh:

Year:  2008        PMID: 18509119     DOI: 10.1056/NEJMp0801872

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  29 in total

1.  Challenging assumptions about minority participation in US clinical research.

Authors:  Jill A Fisher; Corey A Kalbaugh
Journal:  Am J Public Health       Date:  2011-10-20       Impact factor: 9.308

2.  Research participation by low-income and racial/ethnic minority groups: how payment may change the balance.

Authors:  Jennifer K Walter; James F Burke; Matthew M Davis
Journal:  Clin Transl Sci       Date:  2013-07-29       Impact factor: 4.689

3.  Rethinking the vulnerability of minority populations in research.

Authors:  Wendy Rogers; Margaret Meek Lange
Journal:  Am J Public Health       Date:  2013-10-17       Impact factor: 9.308

Review 4.  The use of gastrointestinal intubation studies for controlled release development.

Authors:  Steven C Sutton
Journal:  Br J Clin Pharmacol       Date:  2009-09       Impact factor: 4.335

5.  Response.

Authors:  Christine Grady
Journal:  Clin Trials       Date:  2017-07-14       Impact factor: 2.486

6.  Avoiding Exploitation in Phase I Clinical Trials: More than (Un)Just Compensation.

Authors:  Matt Lamkin; Carl Elliott
Journal:  J Law Med Ethics       Date:  2018-03-27       Impact factor: 1.718

7.  Randomized evaluation of trial acceptability by INcentive (RETAIN): Study protocol for two embedded randomized controlled trials.

Authors:  Dustin C Krutsinger; Jacqueline McMahon; Alisa J Stephens-Shields; Brian Bayes; Steven Brooks; Brian L Hitsman; Su Fen Lubitz; Celine Reyes; Robert A Schnoll; S Ryan Greysen; Ashley Mercede; Mitesh S Patel; Catherine Reale; Fran Barg; Jason Karlawish; Daniel Polsky; Kevin G Volpp; Scott D Halpern
Journal:  Contemp Clin Trials       Date:  2018-11-08       Impact factor: 2.226

Review 8.  Risks of phase I research with healthy participants: A systematic review.

Authors:  Rebecca A Johnson; Annette Rid; Ezekiel Emanuel; David Wendler
Journal:  Clin Trials       Date:  2015-09-08       Impact factor: 2.486

9.  Dignity, Health, and Membership: Who Counts as One of Us?

Authors:  Bryan C Pilkington
Journal:  J Med Philos       Date:  2016-02-11

10.  Bioethical Issues in Providing Financial Incentives to Research Participants.

Authors:  David B Resnik
Journal:  Medicoleg Bioeth       Date:  2015-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.